Pfizer may spark health M&A; not overall catalyst

PHILADELPHIA (Reuters) – Pfizer Inc’s $68 billion deal to buy Wyeth may spark more deals in the healthcare sector, but it is unlikely to revive the flailing merger market.

Leave a Reply